NBW CAPITAL LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
NBW CAPITAL LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$2,710,524
-18.4%
53,973
+2.7%
0.66%
-14.3%
Q2 2023$3,320,528
+37.7%
52,540
-2.0%
0.78%
+32.3%
Q1 2023$2,411,329
+167.3%
53,597
+160.3%
0.59%
+154.8%
Q4 2022$901,960
-61.3%
20,588
-41.9%
0.23%
-63.2%
Q3 2022$2,333,000
+28.5%
35,406
-1.5%
0.62%
+25.5%
Q2 2022$1,816,000
-3.8%
35,945
+21.7%
0.50%
+11.2%
Q1 2022$1,887,000
-40.8%
29,543
-0.8%
0.45%
-36.9%
Q4 2021$3,189,000
+14.1%
29,774
+9.5%
0.71%
+5.5%
Q3 2021$2,796,000
+15.7%
27,196
-1.0%
0.67%
+14.5%
Q2 2021$2,416,000
-8.7%
27,463
+0.9%
0.59%
-19.3%
Q1 2021$2,645,000
-8.0%
27,208
+6.1%
0.73%
-16.6%
Q4 2020$2,876,000
+11.2%
25,646
-8.1%
0.87%
+1.3%
Q3 2020$2,587,000
+22.6%
27,907
+3.2%
0.86%
+13.9%
Q2 2020$2,110,000
+55.9%
27,052
+16.9%
0.76%
+17.7%
Q1 2020$1,353,000
-31.2%
23,140
-5.8%
0.64%
+15.2%
Q4 2019$1,968,000
+10.8%
24,566
+1.6%
0.56%
+5.9%
Q3 2019$1,776,000
-25.1%
24,178
-3.8%
0.53%
-19.0%
Q2 2019$2,371,000
+15.9%
25,134
-1.7%
0.65%
+16.4%
Q1 2019$2,046,000
+49.2%
25,558
+0.5%
0.56%
+15.0%
Q4 2018$1,371,000
-30.8%
25,438
+0.3%
0.49%
-8.6%
Q3 2018$1,980,000
+49.5%
25,362
+21.6%
0.53%
+40.6%
Q2 2018$1,324,000
-16.3%
20,850
+20.9%
0.38%
-23.3%
Q1 2018$1,581,000
-15.7%
17,241
-30.7%
0.49%0.0%
Q4 2017$1,876,000
-8.2%
24,882
-15.2%
0.49%
-11.2%
Q3 2017$2,044,000
+16.4%
29,335
-15.3%
0.56%
+14.2%
Q2 2017$1,756,000
-26.0%
34,648
-41.6%
0.49%
-26.3%
Q1 2017$2,374,000
+42.1%
59,356
-0.4%
0.66%
+37.7%
Q4 2016$1,671,000
+32.3%
59,582
+40.1%
0.48%
+32.2%
Q3 2016$1,263,000
+45.0%
42,520
-1.1%
0.36%
+36.0%
Q2 2016$871,000
+9.4%
42,998
-2.5%
0.27%
+5.5%
Q1 2016$796,000
-32.3%
44,079
-1.2%
0.25%
-29.7%
Q4 2015$1,175,000
+14.7%
44,620
-7.0%
0.36%
+19.2%
Q3 2015$1,024,000
-19.4%
47,974
-0.0%
0.30%
+3.1%
Q2 2015$1,271,00047,9850.29%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders